AegirBio AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was SEK 4.87 million compared to SEK 15.19 million a year ago. Basic loss per share from continuing operations was SEK 0.16 compared to SEK 0.69 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.431 SEK | -4.12% | +1.77% | -63.16% |
08/07 | Sweden's AegirBio Changes Name to Magnasense | MT |
08/07 | AegirBio AB has Changed its Name to Magnasense AB | CI |
1st Jan change | Capi. | |
---|---|---|
-63.16% | 15.31L | |
+4.64% | 21TCr | |
+8.99% | 18TCr | |
+29.83% | 16TCr | |
+35.17% | 11TCr | |
+2.55% | 6.65TCr | |
+15.06% | 5.39TCr | |
-6.47% | 4.63TCr | |
-2.14% | 3.82TCr | |
+6.88% | 3.66TCr |
- Stock Market
- Equities
- MAGNA Stock
- News Magnasense AB
- AegirBio AB Reports Earnings Results for the First Quarter Ended March 31, 2024